1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe Psychedelic Innovation Fund (PIF) supports human clinical trials, access for underserved populations, education and training in psychedelic medicine and science, and innovation in creating affordable, sustainable, and scalable psychedelic-based care models.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Organizations aligned with the mission to advance evidence-based use of psychedelic medicines and psychedelic-assisted therapies for mental health and neuroscience disorders. Confirm the full requirements in the official notice before applying.
Psychedelic Innovation Fund is funded by Psychedelic Innovation Fund (in partnership with Psychedelic Science Institute and Legacy Global Programs). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Psychedelic Innovation Fund is sponsored by Psychedelic Science Institute (PSI) / Legacy Global Programs. The Psychedelic Innovation Fund, a fiscal sponsorship program of Legacy Global Programs (a 501(c)(3) nonprofit), supports the mission of the Psychedelic Science Institute to advance psychedelic science, expand equitable access to therapies, support education and training, and in…
Psychedelic Innovation Fund is sponsored by Psychedelic Innovation Fund (PIF) / Legacy Global Programs. The Psychedelic Innovation Fund, the philanthropic partner of the Psychedelic Science Institute (PSI), funds cutting-edge clinical trials and research on psychedelics like psilocybin, MDMA, and LSD. The fund aims to advance psychedelic science, expand equitable access to psychedelic-assisted therapies for diverse and underserved populations, and support education and training in the field. It also innovates in creating psychedelic-based care models.
A new Partnership for Public Service report documents 118,000 science-related federal departures between September 2024 and February 2026 — Forest Service and NSF down a third, SAMHSA down 42 percent. Project grant obligations from science agencies dropped 24 percent from 2024 to 2025. On June 3, Johns Hopkins announced a $60M annual Research Resilience Fund. Here is what the data and the institutional response mean for grant applicants.
Read articleOn July 20, 2026, the EDA announced it intends to invest $169 million across six Regional Technology and Innovation Hubs — quantum, nuclear, critical minerals, biosecure manufacturing, pharmaceuticals, and forest bioproducts — after the Trump administration rescinded the Biden-era Phase 2 awards and reran the competition. Only two of the original winners survived. Here is the full breakdown of the six hubs, why four prior awardees were dropped, and what the re-award teaches regional coalitions about competing for the next round.
Read articleThe Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read article